1997
DOI: 10.1017/s1041610297004845
|View full text |Cite
|
Sign up to set email alerts
|

The Interview for Deterioration in Daily Living Activities in Dementia: Agreement Between Primary and Secondary Caregivers

Abstract: Inability to perform activities of daily life is inherent to dementia and an essential component of its severity. Examination of this disability is crucial for diagnosis, management of the patient and family, and evaluation of treatment effects. To examine everyday disability in community-dwelling patients with mild dementia, we developed the Interview for Deterioration in Daily living Activities in Dementia (IDDD) at the memory clinic of the Academic Medical Center at Amsterdam. The IDDD is a caregiver-based … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
61
0
1

Year Published

2007
2007
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 65 publications
(62 citation statements)
references
References 4 publications
0
61
0
1
Order By: Relevance
“…Patients were evaluated clinically by the same neurologist (AWL) at baseline, at 3 months and 6 months after receiving rivastigmine. Clinical tests included: MMSE; Interview for Deterioration in Daily Living (IDDD), an 11-item paper-and-pencil questionnaire, which is completed by the caregiver, covering self-care activities such as dressing and eating, and complex instrumental activities such as shopping and taking care of financial affairs, total scores range from 0 (no assistance required for any activity) to 44 (always assistance required for all activities) [29] ; NPI, a widely used measure of dementia-associated neuropsychiatric disturbances [30] ; Unified Parkinson Disease Rating Scale-motor part (UPDRS-III) [31] ; and the Clinician Assessment of Fluctuation (CAF), a series of screening questions regarding fluctuating confusion and impaired consciousness, producing a severity score from 0 to 12 (0 representing no fluctuating confu-sion, 12 representing severe fluctuating confusion) [32] . Medication doses and side effects were noted separately.…”
Section: Discussionmentioning
confidence: 99%
“…Patients were evaluated clinically by the same neurologist (AWL) at baseline, at 3 months and 6 months after receiving rivastigmine. Clinical tests included: MMSE; Interview for Deterioration in Daily Living (IDDD), an 11-item paper-and-pencil questionnaire, which is completed by the caregiver, covering self-care activities such as dressing and eating, and complex instrumental activities such as shopping and taking care of financial affairs, total scores range from 0 (no assistance required for any activity) to 44 (always assistance required for all activities) [29] ; NPI, a widely used measure of dementia-associated neuropsychiatric disturbances [30] ; Unified Parkinson Disease Rating Scale-motor part (UPDRS-III) [31] ; and the Clinician Assessment of Fluctuation (CAF), a series of screening questions regarding fluctuating confusion and impaired consciousness, producing a severity score from 0 to 12 (0 representing no fluctuating confu-sion, 12 representing severe fluctuating confusion) [32] . Medication doses and side effects were noted separately.…”
Section: Discussionmentioning
confidence: 99%
“…The 33 items are assessed on a seven-point scale. 319 It was initially designed for use in a 15-minute carer interview, but there is now a self-complete version for the carer.…”
Section: Interview For Deterioration In Daily Living Activities In Dementioning
confidence: 99%
“…A large number of assessment scales have been developed to assess IADL (Burns, Lawlor, & Craig, 2004;Keith, Granger, Hamilton, & Sherwin, 1987;Lindeboom, Vermeulen, Math, & De Haan, 2003;Moore, Palmer, Patterson, & Jeste, 2007;Sikkes, de Lange-de Klerk, Pijnenburg, Scheltens, & Uitdehaag, 2009;Teunisse & Derix, 1997;Voigt-Radloff, Leonhart, Schützwohl, Jurianz, Reuster, Gerner et al, 2012). The typical purposes of these scales are to screen a population in terms of general levels of functional independence and to assess the severity of symptoms for a small number of activities (Athlin, Norberg, Axelsson, Moller, & Nordstrom, 1989;Beck, 1988;Galasko, Bennett, Sano, Ernesto, Thomas, Grundman et al, 1997;Kuriansky & Gurland, 1976;Lawton & Brody, 1969;Loewenstein, Amigo, Duara, Guterman, Hurwitz, Wilkie et al, 1989;LucasBlaustein, Filipp, Dungan, & Tune, 1988;Oakley, Sunderland, Hill, Phillips, Makahon, & Ebner, 1991;Teunisse & Derix, 1997).…”
Section: Profinteg: a Tool For Real-life Assessment Of Activities Of mentioning
confidence: 99%
“…The typical purposes of these scales are to screen a population in terms of general levels of functional independence and to assess the severity of symptoms for a small number of activities (Athlin, Norberg, Axelsson, Moller, & Nordstrom, 1989;Beck, 1988;Galasko, Bennett, Sano, Ernesto, Thomas, Grundman et al, 1997;Kuriansky & Gurland, 1976;Lawton & Brody, 1969;Loewenstein, Amigo, Duara, Guterman, Hurwitz, Wilkie et al, 1989;LucasBlaustein, Filipp, Dungan, & Tune, 1988;Oakley, Sunderland, Hill, Phillips, Makahon, & Ebner, 1991;Teunisse & Derix, 1997). This restriction does not offer the clinician the opportunity to establish a complete profile of the patient's difficulties, while s/he is still attempting to carry out many daily activities.…”
Section: Profinteg: a Tool For Real-life Assessment Of Activities Of mentioning
confidence: 99%
See 1 more Smart Citation